Signature Cord Prime Phase 1 Study for Knee OA

Signature Biologics Cord

Signature Biologics received FDA approval of an Investigational New Drug Application (IND) to proceed with the study of Signature Cord Prime™ in patients with symptomatic knee osteoarthritis (OA).

Signature Cord Prime cryopreserved, human umbilical cord tissue allograft comprises micronized umbilical cord tissue. The product contains...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0